Insys Therapeutics posts $57.42 million net loss for June 10-June 30

By Caroline Salls

Pittsburgh, Aug. 13 – Insys Therapeutics, Inc. reported a $57.42 million net loss for the period of June 10 through June 30 on $2.25 million in net revenue, according to its monthly operating report filed Tuesday with the Securities and Exchange Commission.

The company had $22.33 million in cash and cash equivalents as of June 30.

The specialty pharmaceutical company is based in Phoenix. The company filed bankruptcy on June 10 in the U.S. Bankruptcy Court for the District of Delaware under Chapter 11 case number 19-11292.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.